Neuroprotection and neuroregeneration treatment strategy in non-arteritic anterior ischemic optic neuropathy / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
; (12): 675-679, 2022.
Article
en Zh
| WPRIM
| ID: wpr-955300
Biblioteca responsable:
WPRO
ABSTRACT
Non-arteritic anterior ischemic optic neuropathy (NAION) is a disease characterized by acute, painless visual acuity loss and visual field impairment, and there is still lack of unified and effective treatment.As new therapeutic strategies, neuroprotection and nerve regeneration have aroused wide public concern, which aim to prevent degeneration and death of neurons or establish a new neural circuit through inhibiting apoptosis pathway and inflammation, promoting axon growth and applying stem cells.Plenty of studies have applied the strategies to NAION patients or NAION animal models, which achieved certain success, but the limitations exist at the same time.For the sake of exploring practical therapies of NAION, researches on the neuroprotection and nerve regeneration strategies of NAION in recent years were reviewed in this article.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Experimental Ophthalmology
Año:
2022
Tipo del documento:
Article